UniProt ID | PJA2_HUMAN | |
---|---|---|
UniProt AC | O43164 | |
Protein Name | E3 ubiquitin-protein ligase Praja-2 | |
Gene Name | PJA2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 708 | |
Subcellular Localization |
Cytoplasm . Cell membrane . Endoplasmic reticulum membrane Peripheral membrane protein . Golgi apparatus membrane Peripheral membrane protein . Cell junction, synapse. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density. Loca |
|
Protein Description | Has E2-dependent E3 ubiquitin-protein ligase activity. Responsible for ubiquitination of cAMP-dependent protein kinase type I and type II-alpha/beta regulatory subunits and for targeting them for proteasomal degradation. Essential for PKA-mediated long-term memory processes.. | |
Protein Sequence | MSQYTEKEPAAMDQESGKAVWPKPAGGYQTITGRRYGRRHAYVSFKPCMTRHERSLGRAGDDYEVLELDDVPKENSSGSSPLDQVDSSLPSEPIFEKSETEIPTCGSALNQTTESSQSFVAVHHSEEGRDTLGSSTNLHNHSEGEYIPGACSASSVQNGIALVHTDSYDPDGKHGEDNDHLQLSAEVVEGSRYQESLGNTVFELENREAEAYTGLSPPVPSFNCEVRDEFEELDSVPLVKSSAGDTEFVHQNSQEIQRSSQDEMVSTKQQNNTSQERQTEHSPEDAACGPGHICSEQNTNDREKNHGSSPEQVVRPKVRKLISSSQVDQETGFNRHEAKQRSVQRWREALEVEESGSDDLLIKCEEYDGEHDCMFLDPPYSRVITQRETENNQMTSESGATAGRQEVDNTFWNGCGDYYQLYDKDEDSSECSDGEWSASLPHRFSGTEKDQSSSDESWETLPGKDENEPELQSDSSGPEEENQELSLQEGEQTSLEEGEIPWLQYNEVNESSSDEGNEPANEFAQPAFMLDGNNNLEDDSSVSEDLDVDWSLFDGFADGLGVAEAISYVDPQFLTYMALEERLAQAMETALAHLESLAVDVEVANPPASKESIDGLPETLVLEDHTAIGQEQCCPICCSEYIKDDIATELPCHHFFHKPCVSIWLQKSGTCPVCRRHFPPAVIEASAAPSSEPDPDAPPSNDSIAEAP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSQYTEKEP ------CCCCCCCCC | 31.71 | - | |
2 | Phosphorylation | ------MSQYTEKEP ------CCCCCCCCC | 31.71 | 23186163 | |
4 | Phosphorylation | ----MSQYTEKEPAA ----CCCCCCCCCCC | 15.01 | 20068231 | |
5 | Phosphorylation | ---MSQYTEKEPAAM ---CCCCCCCCCCCC | 32.70 | 23186163 | |
16 | Phosphorylation | PAAMDQESGKAVWPK CCCCCCCCCCEECCC | 39.70 | 28985074 | |
18 | Ubiquitination | AMDQESGKAVWPKPA CCCCCCCCEECCCCC | 49.39 | 29967540 | |
28 | Phosphorylation | WPKPAGGYQTITGRR CCCCCCCEEEECCCE | 11.10 | 28796482 | |
30 | Phosphorylation | KPAGGYQTITGRRYG CCCCCEEEECCCEEC | 16.42 | - | |
42 | Phosphorylation | RYGRRHAYVSFKPCM EECCCEEEEEECCCC | 7.18 | 28796482 | |
44 | Phosphorylation | GRRHAYVSFKPCMTR CCCEEEEEECCCCCH | 18.18 | 30576142 | |
46 | Acetylation | RHAYVSFKPCMTRHE CEEEEEECCCCCHHH | 29.78 | 23749302 | |
46 | Methylation | RHAYVSFKPCMTRHE CEEEEEECCCCCHHH | 29.78 | 66725095 | |
50 | Phosphorylation | VSFKPCMTRHERSLG EEECCCCCHHHHHHC | 35.27 | 26434776 | |
63 | Phosphorylation | LGRAGDDYEVLELDD HCCCCCCEEEEEHHC | 16.81 | 28796482 | |
76 | Phosphorylation | DDVPKENSSGSSPLD HCCCCCCCCCCCCHH | 36.85 | 22199227 | |
77 | Phosphorylation | DVPKENSSGSSPLDQ CCCCCCCCCCCCHHH | 55.03 | 22199227 | |
79 | Phosphorylation | PKENSSGSSPLDQVD CCCCCCCCCCHHHCC | 30.63 | 22199227 | |
80 | Phosphorylation | KENSSGSSPLDQVDS CCCCCCCCCHHHCCC | 32.76 | 26657352 | |
87 | Phosphorylation | SPLDQVDSSLPSEPI CCHHHCCCCCCCCCC | 34.61 | 22199227 | |
88 | Phosphorylation | PLDQVDSSLPSEPIF CHHHCCCCCCCCCCC | 39.57 | 22199227 | |
91 | Phosphorylation | QVDSSLPSEPIFEKS HCCCCCCCCCCCCCC | 62.39 | 26074081 | |
134 | Phosphorylation | EGRDTLGSSTNLHNH CCCCCCCCCCCCCCC | 36.78 | 24275569 | |
152 | Phosphorylation | EYIPGACSASSVQNG CCCCCCCCCCHHCCC | 30.56 | 28348404 | |
154 | Phosphorylation | IPGACSASSVQNGIA CCCCCCCCHHCCCEE | 18.10 | 28348404 | |
155 | Phosphorylation | PGACSASSVQNGIAL CCCCCCCHHCCCEEE | 27.69 | 28348404 | |
165 | Phosphorylation | NGIALVHTDSYDPDG CCEEEEECCCCCCCC | 21.11 | 28348404 | |
167 | Phosphorylation | IALVHTDSYDPDGKH EEEEECCCCCCCCCC | 32.37 | 28348404 | |
168 | Phosphorylation | ALVHTDSYDPDGKHG EEEECCCCCCCCCCC | 34.01 | 28348404 | |
193 | Phosphorylation | EVVEGSRYQESLGNT EHHHCCHHHHHHCCE | 20.52 | 20873877 | |
196 | Phosphorylation | EGSRYQESLGNTVFE HCCHHHHHHCCEEEE | 26.50 | 23663014 | |
200 | Phosphorylation | YQESLGNTVFELENR HHHHHCCEEEEEECC | 25.44 | 20873877 | |
212 | Phosphorylation | ENREAEAYTGLSPPV ECCCHHHHCCCCCCC | 7.89 | 28796482 | |
213 | Phosphorylation | NREAEAYTGLSPPVP CCCHHHHCCCCCCCC | 38.40 | 28796482 | |
216 | Phosphorylation | AEAYTGLSPPVPSFN HHHHCCCCCCCCCCC | 28.62 | 25159151 | |
221 | Phosphorylation | GLSPPVPSFNCEVRD CCCCCCCCCCEEECH | 29.35 | 28387310 | |
235 | Phosphorylation | DEFEELDSVPLVKSS HHHHHHCCCCEEECC | 37.95 | 19664994 | |
241 | Phosphorylation | DSVPLVKSSAGDTEF CCCCEEECCCCCCCC | 20.24 | 29691806 | |
242 | Phosphorylation | SVPLVKSSAGDTEFV CCCEEECCCCCCCCC | 30.47 | 29691806 | |
246 | Phosphorylation | VKSSAGDTEFVHQNS EECCCCCCCCCCCCH | 30.33 | 29691806 | |
253 | Phosphorylation | TEFVHQNSQEIQRSS CCCCCCCHHHHHHHC | 23.71 | 23401153 | |
259 | Phosphorylation | NSQEIQRSSQDEMVS CHHHHHHHCHHHHHH | 18.90 | 21406692 | |
260 | Phosphorylation | SQEIQRSSQDEMVST HHHHHHHCHHHHHHH | 43.79 | 21406692 | |
266 | Phosphorylation | SSQDEMVSTKQQNNT HCHHHHHHHHHHCCC | 28.69 | 21406692 | |
267 | Phosphorylation | SQDEMVSTKQQNNTS CHHHHHHHHHHCCCH | 22.82 | 21406692 | |
268 (in isoform 1) | Ubiquitination | - | 42.24 | 21890473 | |
268 | Ubiquitination | QDEMVSTKQQNNTSQ HHHHHHHHHHCCCHH | 42.24 | 27667366 | |
268 (in isoform 2) | Ubiquitination | - | 42.24 | 21890473 | |
273 | Phosphorylation | STKQQNNTSQERQTE HHHHHCCCHHHHHHC | 39.06 | 29759185 | |
274 | Phosphorylation | TKQQNNTSQERQTEH HHHHCCCHHHHHHCC | 31.97 | 21406692 | |
282 | Phosphorylation | QERQTEHSPEDAACG HHHHHCCCCCHHCCC | 24.61 | 25159151 | |
304 | Ubiquitination | QNTNDREKNHGSSPE CCCCHHHHCCCCCHH | 55.95 | 29967540 | |
308 | Phosphorylation | DREKNHGSSPEQVVR HHHHCCCCCHHHHHC | 34.86 | 30266825 | |
309 | Phosphorylation | REKNHGSSPEQVVRP HHHCCCCCHHHHHCH | 36.73 | 25159151 | |
317 | Ubiquitination | PEQVVRPKVRKLISS HHHHHCHHHHHHHCC | 44.07 | 23000965 | |
320 | Ubiquitination | VVRPKVRKLISSSQV HHCHHHHHHHCCCCC | 53.83 | 23000965 | |
320 (in isoform 1) | Ubiquitination | - | 53.83 | 21890473 | |
320 (in isoform 2) | Ubiquitination | - | 53.83 | 21890473 | |
323 | Phosphorylation | PKVRKLISSSQVDQE HHHHHHHCCCCCCHH | 34.08 | 30266825 | |
324 | Phosphorylation | KVRKLISSSQVDQET HHHHHHCCCCCCHHH | 20.14 | 30266825 | |
325 | Phosphorylation | VRKLISSSQVDQETG HHHHHCCCCCCHHHC | 27.68 | 19690332 | |
339 | Ubiquitination | GFNRHEAKQRSVQRW CCCHHHHHHHHHHHH | 43.17 | 21890473 | |
339 (in isoform 2) | Ubiquitination | - | 43.17 | 21890473 | |
339 (in isoform 1) | Ubiquitination | - | 43.17 | 21890473 | |
342 | Phosphorylation | RHEAKQRSVQRWREA HHHHHHHHHHHHHHH | 21.80 | 21423175 | |
355 | Phosphorylation | EALEVEESGSDDLLI HHHHHHHHCCCCEEE | 30.05 | 20873877 | |
357 | Phosphorylation | LEVEESGSDDLLIKC HHHHHHCCCCEEEEE | 36.91 | 20873877 | |
367 | Phosphorylation | LLIKCEEYDGEHDCM EEEEEEEECCCCCEE | 13.62 | - | |
380 | Phosphorylation | CMFLDPPYSRVITQR EEEECCCCCEEEEEH | 17.94 | 22817900 | |
381 | Phosphorylation | MFLDPPYSRVITQRE EEECCCCCEEEEEHH | 26.33 | 22817900 | |
385 | Phosphorylation | PPYSRVITQRETENN CCCCEEEEEHHCCCC | 20.79 | 22817900 | |
389 | Phosphorylation | RVITQRETENNQMTS EEEEEHHCCCCCCCC | 46.32 | 20873877 | |
395 | Phosphorylation | ETENNQMTSESGATA HCCCCCCCCCCCCCC | 21.41 | 20873877 | |
396 | Phosphorylation | TENNQMTSESGATAG CCCCCCCCCCCCCCC | 25.15 | 20873877 | |
398 | Phosphorylation | NNQMTSESGATAGRQ CCCCCCCCCCCCCCH | 33.23 | 20873877 | |
428 | Phosphorylation | LYDKDEDSSECSDGE EEECCCCCCCCCCCC | 26.45 | 25159151 | |
429 | Phosphorylation | YDKDEDSSECSDGEW EECCCCCCCCCCCCE | 55.75 | 25159151 | |
432 | Phosphorylation | DEDSSECSDGEWSAS CCCCCCCCCCCEECC | 44.60 | 25159151 | |
437 | Phosphorylation | ECSDGEWSASLPHRF CCCCCCEECCCCCCC | 12.04 | 27251275 | |
452 | Phosphorylation | SGTEKDQSSSDESWE CCCCCCCCCCCCCCC | 41.78 | 20363803 | |
453 | Phosphorylation | GTEKDQSSSDESWET CCCCCCCCCCCCCCC | 35.85 | 20363803 | |
454 | Phosphorylation | TEKDQSSSDESWETL CCCCCCCCCCCCCCC | 51.12 | 20363803 | |
457 | Phosphorylation | DQSSSDESWETLPGK CCCCCCCCCCCCCCC | 34.89 | 20363803 | |
460 | Phosphorylation | SSDESWETLPGKDEN CCCCCCCCCCCCCCC | 31.81 | 25159151 | |
486 | Phosphorylation | EEENQELSLQEGEQT HHHHHCCCCCCCCCC | 27.53 | 26074081 | |
493 | Phosphorylation | SLQEGEQTSLEEGEI CCCCCCCCCCCCCCC | 30.86 | 26074081 | |
494 | Phosphorylation | LQEGEQTSLEEGEIP CCCCCCCCCCCCCCC | 33.21 | 26074081 | |
576 | Phosphorylation | VDPQFLTYMALEERL CCHHHHHHHHHHHHH | 5.20 | 22817900 | |
596 | Phosphorylation | TALAHLESLAVDVEV HHHHHHHHHCCEEEE | 28.17 | 24275569 | |
647 (in isoform 2) | Ubiquitination | - | 11.30 | 21890473 | |
658 | Ubiquitination | PCHHFFHKPCVSIWL CCCHHCCCCEEEEEE | 34.65 | 29967540 | |
667 | Ubiquitination | CVSIWLQKSGTCPVC EEEEEEECCCCCCCC | 49.00 | 22817900 | |
667 (in isoform 1) | Ubiquitination | - | 49.00 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
342 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
342 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
342 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
389 | T | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
389 | T | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
389 | T | Phosphorylation | Kinase | PKA | - | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | PJA2 | O43164 | PMID:22199232 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PJA2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PJA2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
UB2D2_HUMAN | UBE2D2 | physical | 12036302 | |
KAP2_HUMAN | PRKAR2A | physical | 21423175 | |
KAP0_HUMAN | PRKAR1A | physical | 21423175 | |
UB2D3_HUMAN | UBE2D3 | physical | 21423175 | |
PJA2_HUMAN | PJA2 | physical | 12036302 | |
KSR1_HUMAN | KSR1 | physical | 27195677 | |
MFHA1_HUMAN | MFHAS1 | physical | 28471450 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Control of PKA stability and signalling by the RING ligase praja2."; Lignitto L., Carlucci A., Sepe M., Stefan E., Cuomo O., Nistico R.,Scorziello A., Savoia C., Garbi C., Annunziato L., Feliciello A.; Nat. Cell Biol. 13:412-422(2011). Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH PRKAR1A; PRKAR2A ANDPRKAR2B, AND PHOSPHORYLATION AT SER-342 AND THR-389. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-380; SER-381; THR-385;SER-428; SER-429 AND SER-432, AND MASS SPECTROMETRY. |